Abreu Lab
The Abreu Lab team researches inflammatory bowel diseases (IBD) and colon cancer, focusing on the relationship between the host and the gut microbiota. Dysregulation of the host-microbiota relationship can lead to gut inflammation and tumorigenesis. Her lab is also interested in understanding how environmental and genetic factors interact to explain the rising incidence of IBD in the immigrant Hispanic population.
Personal Statement
I am a world-renowned physician-scientist and gastroenterologist who specializes in IBD, bringing discoveries from the lab bench to the patient bedside. Understanding how diet may shape the gut microbiome and alleviate IBD symptoms can lead to targeted treatment strategies to help our patients live their best lives.
Maria T. Abreu, MD
Breakthrough Research
Dr. Abreu’s laboratory conducts both basic science and clinical/translational research to elucidate the causes and consequences of inflammatory bowel diseases.
Funded Research
Our cutting-edge research is funded by a variety of sources, including the National Institutes of Health, the Crohn’s & Colitis Foundation and Pfizer, Inc.
Publications
Learn more about the recent research publications from the Abreu Lab.
Laboratory Team
Learn more about the Abreu Laboratory team, whose dedicated efforts lead to groundbreaking discoveries.
Job Opportunities
We are actively recruiting research assistants and postdocs to join our laboratory, bringing their expertise to make important breakthroughs.
Collaborations
The Abreu Lab collaborates with a wide range of investigators within Cedars-Sinai and in institutions around the world.
Contact the Abreu Lab
110 N. George Burns Rd.
Davis Building, Suite D4063
Los Angeles, CA 90048